Mutation type is not clinically useful in predicting prognosis in hypertrophic cardiomyopathy.
dc.contributor.author | Landstrom, AP | |
dc.contributor.author | Ackerman, MJ | |
dc.date.accessioned | 2020-04-01T13:45:54Z | |
dc.date.available | 2020-04-01T13:45:54Z | |
dc.date.issued | 2010-12 | |
dc.date.updated | 2020-04-01T13:45:53Z | |
dc.identifier | 122/23/2441 | |
dc.identifier.issn | 0009-7322 | |
dc.identifier.issn | 1524-4539 | |
dc.identifier.uri | ||
dc.language | eng | |
dc.publisher | Ovid Technologies (Wolters Kluwer Health) | |
dc.relation.ispartof | Circulation | |
dc.relation.isversionof | 10.1161/CIRCULATIONAHA.110.954446 | |
dc.subject | Humans | |
dc.subject | Cardiomyopathy, Hypertrophic | |
dc.subject | Prognosis | |
dc.subject | Predictive Value of Tests | |
dc.subject | Genotype | |
dc.subject | Mutation | |
dc.title | Mutation type is not clinically useful in predicting prognosis in hypertrophic cardiomyopathy. | |
dc.type | Journal article | |
duke.contributor.orcid | Landstrom, AP|0000-0002-1878-9631 | |
pubs.begin-page | 2441 | |
pubs.end-page | 2450 | |
pubs.issue | 23 | |
pubs.organisational-group | School of Medicine | |
pubs.organisational-group | Cell Biology | |
pubs.organisational-group | Pediatrics, Cardiology | |
pubs.organisational-group | Duke | |
pubs.organisational-group | Basic Science Departments | |
pubs.organisational-group | Pediatrics | |
pubs.organisational-group | Clinical Science Departments | |
pubs.publication-status | Published | |
pubs.volume | 122 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Review - Mutation Prognosis in HCM.pdf
- Size:
- 902.34 KB
- Format:
- Adobe Portable Document Format